|
|||||
Transplant Statistics: Annual Report
| Table 14.2 |
| Recipient Recurrence of Pretransplant Malignancies, 1991 to 2000 |
| by Transplant Type |
| Organ Type | Year of Transplant | ||||||||||
| 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | ||
| Total | Total Recipients | 15,751 | 16,131 | 17,641 | 18,308 | 19,365 | 19,718 | 20,277 | 21,442 | 21,762 | 22,965 |
| # With Pre-Tx Malignancy (1) | 1 | 3 | 2 | 197 | 355 | 431 | 468 | 544 | 687 | 793 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | 2 | 3 | 5 | 16 | 12 | 13 | 7 | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | 1.0% | 0.8% | 1.2% | 3.4% | 2.2% | 1.9% | 0.9% | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | 11 | 11 | 14 | 18 | 21 | 18 | 27 | 37 | 16 | 11 | |
| Kidney | Total Recipients | 9,674 | 9,736 | 10,361 | 10,645 | 11,051 | 11,361 | 11,673 | 12,376 | 12,548 | 13,371 |
| # With Pre-Tx Malignancy (1) | 1 | 1 | 2 | 80 | 164 | 197 | 228 | 256 | 318 | 319 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | 2 | 1 | 1 | 6 | 2 | 3 | 2 | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | 2.5% | 0.6% | 0.5% | 2.6% | 0.8% | 0.9% | 0.6% | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | 2 | 5 | 2 | 6 | 6 | 7 | 6 | 6 | 4 | 2 | |
| Pancreas | Total Recipients | 78 | 64 | 113 | 94 | 107 | 165 | 208 | 246 | 361 | 436 |
| # With Pre-Tx Malignancy (1) | - | - | - | - | 1 | 1 | 3 | 3 | 5 | 13 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | - | - | - | - | - | - | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | - | - | - | - | - | - | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | - | - | - | - | - | - | - | - | - | - | |
| Kidney-Pancreas | Total Recipients | 452 | 493 | 661 | 748 | 918 | 860 | 852 | 971 | 934 | 911 |
| # With Pre-Tx Malignancy (1) | - | - | - | 2 | 8 | 4 | 5 | 10 | 9 | 11 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | 1 | - | - | - | - | - | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | 12.5% | - | - | - | - | - | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | - | - | - | 1 | 1 | - | - | 1 | - | - | |
| Liver | Total Recipients | 2,953 | 3,064 | 3,440 | 3,652 | 3,924 | 4,072 | 4,176 | 4,503 | 4,708 | 4,954 |
| # With Pre-Tx Malignancy (1) | - | - | - | 77 | 112 | 144 | 141 | 177 | 264 | 359 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | - | 3 | 8 | 9 | 9 | 5 | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | - | 2.1% | 5.7% | 5.1% | 3.4% | 1.4% | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | 6 | 5 | 6 | 7 | 9 | 8 | 19 | 28 | 11 | 8 | |
| Intestine | Total Recipients | 12 | 22 | 34 | 23 | 45 | 45 | 68 | 69 | 71 | 79 |
| # With Pre-Tx Malignancy (1) | - | - | - | - | 1 | 2 | 3 | 2 | - | 3 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | - | - | - | - | - | - | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | - | - | - | - | - | - | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | - | - | - | - | 1 | - | - | - | - | - | |
| Heart | Total Recipients | 2,126 | 2,169 | 2,298 | 2,339 | 2,359 | 2,343 | 2,295 | 2,345 | 2,181 | 2,198 |
| # With Pre-Tx Malignancy (1) | - | 2 | - | 36 | 57 | 61 | 71 | 73 | 72 | 63 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | 1 | 1 | 1 | 1 | 1 | - | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | 1.8% | 1.6% | 1.4% | 1.4% | 1.4% | - | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | 3 | 1 | 5 | 3 | 3 | 2 | 1 | 1 | 1 | - | |
| Lung | Total Recipients | 405 | 535 | 674 | 736 | 892 | 832 | 945 | 887 | 910 | 968 |
| # With Pre-Tx Malignancy (1) | - | - | - | 2 | 12 | 22 | 17 | 23 | 19 | 24 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | - | - | 1 | - | - | - | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | - | - | 5.9% | - | - | - | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | - | - | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | |
| Heart-Lung | Total Recipients | 51 | 48 | 60 | 71 | 69 | 40 | 60 | 45 | 49 | 48 |
| # With Pre-Tx Malignancy (1) | - | - | - | - | - | - | - | - | - | 1 | |
| # With Recurrence of Pre-Tx Malignancy (2) | - | - | - | - | - | - | - | - | - | - | |
| % With Recurrence of Pre-Tx Malignancy (3) | - | - | - | - | - | - | - | - | - | - | |
| # With Recurrence, but no Pre-Tx Malignancy (4) | - | - | - | - | - | - | - | - | - | - | |
| Source: OPTN/SRTR Data as of August 1, 2001. |
| (-) = None in category. |
| Includes both cadaveric and living donor transplants. |
| (1) Pre-Tx malignancy reported on the TCR or TRR form. |
| (2) Recurrence reported on the Transplant Recipient Follow-up form. |
| (3) Percent recurrence is calculated based on total with reported pre-tx malignancy. |
| (4) Recurrence reported on the follow-up form, but no pre-tx malignancy reported, so these are not included in recurrence rates. |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.